WO2005067633B1 - Method and apparatus for presentation of noninvasive glucose concentration information - Google Patents

Method and apparatus for presentation of noninvasive glucose concentration information

Info

Publication number
WO2005067633B1
WO2005067633B1 PCT/US2005/000420 US2005000420W WO2005067633B1 WO 2005067633 B1 WO2005067633 B1 WO 2005067633B1 US 2005000420 W US2005000420 W US 2005000420W WO 2005067633 B1 WO2005067633 B1 WO 2005067633B1
Authority
WO
WIPO (PCT)
Prior art keywords
glucose
concentrations
module
historical
concentration
Prior art date
Application number
PCT/US2005/000420
Other languages
French (fr)
Other versions
WO2005067633A3 (en
WO2005067633A2 (en
Inventor
Linda Hockersmith
Kevin H Hazen
Timothy L Ruchti
Original Assignee
Sensys Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensys Medical Inc filed Critical Sensys Medical Inc
Publication of WO2005067633A2 publication Critical patent/WO2005067633A2/en
Publication of WO2005067633A3 publication Critical patent/WO2005067633A3/en
Publication of WO2005067633B1 publication Critical patent/WO2005067633B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0456—Apparatus provided with a docking unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7405—Details of notification to user or communication with user or patient ; user input means using sound
    • A61B5/7415—Sound rendering of measured values, e.g. by pitch or volume variation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • A61B5/749—Voice-controlled interfaces

Abstract

The invention relates generally to the extraction and/or presentation of glucose concentrations estimated as a function of time into a format that facilitates conveyance of the underlying information. More particularly, glucose concentration histories are presented in terms of risk of behavior, in a video format, and/or in an audio format. The reduction of data into video format, selected by time period, cluster, or glucose concentration response, into an animated or video presentation allows diagnosis and treatment information to be more readily determined and used. Alternatively, glucose concentrations are output through a voice synthesizer or an earcon. These information presentations are useful for both the medical professional and the end user. The information presentation is preferably used with a noninvasive, implantable, semi-continuous, and/or continuous analyte analyzer, such as a glucose comcentration analyzer.

Claims

57 AMENDED CLAIMS[received by the International Bureau on 26 May 2006 (26.05.06)]
1. An apparatus for analyte concentration display, comprising: a near-infrared analyzer, a display module integrated into said analyzer; and means for video graphic display of historical analyte concentrations in a time compressed format on said display module.
2. The apparatus of Claim 1 , wherein said historical analyte concentrations represent at least five glucose concentrations.
3. The apparatus of Claim 1 , wherein said display module comprises a color display screen.
4. The apparatus of Claim 3, said historical analyte concentrations further comprising at least three physiological glucose concentration ranges, wherein said video graphic display represents said historical glucose concentrations for each of said ranges in different colors.
5. The apparatus of Claim 4, wherein said physiological glucose concentration ranges comprise at least two of: a range of hyperglycemic glucose concentrations; a range of normal glucose concentrations; a range of hypoglycemic glucose concentrations; and a targeted glucose concentration range.
6. The apparatus of Claim 3, wherein said display module comprises an input touch screen. 58
7. The apparatus of Claim 2, said historical aπalyte concentrations further comprising a time period, wherein said video graphic display represents glucose concentrations within said time period.
8. The apparatus of Claim 7, wherein said time period comprises a period of any of about: a period of a glucose excursion; a day; a week; a month; and several months.
9. The apparatus of Claim 8, wherein said video graphic display comprises any of: a slider graph; a bar graph; a treadmill graph; and a tachometer graph.
10. The apparatus of Claim 9, wherein said video graphic display comprises a first animated graphical representation of at least one of said historical glucose concentrations.
11. The apparatus of Claim 10, wherein said first animated graphical representation represents any of; a current time stamped glucose concentration; and 59
an individual glucose concentration, wherein said individual glucose concentration comprises one of said historical analyte concentrations.
12. The apparatus of Claim 11 , wherein said video graphic display comprises a second animated graphical representation of any of: a maximum achieved glucose concentration; a minimum achieved glucose concentration; a targeted glucose concentration; a targeted maximum glucose concentration; and a targeted minimum glucose concentration.
13. The apparatus of Claim 1 , wherein said analyzer comprises: a base module in a first container; a communication bundle having a first end and a second end, wherein said first end connects to said base module; and a sample module in a second container separated from said first container, wherein said second end of said communication bundle connects to said sample module.
14. The apparatus of Claim 7, further comprising a user interface.
15. The apparatus of Claim 14, wherein said time period is controlled through said user interface.
16. An apparatus for representation of data associated with historical noninvasive glucose concentrations, comprising: a near-infrared based noninvasive glucose analyzer; means for selection of a cluster of data contained in said analyzer; 60
means for selecting values of variables associated with points in said cluster; and means for presentation of said values.
17. The apparatus of Claim 16, wherein said analyzer comprises of: a sample module in a first housing; a base module in a second housing; and means for communication between said sample module and said base module.
18. The apparatus of Claim 16, wherein said duster of data comprises any of: a cluster of said glucose concentrations; a range of said glucose concentrations; and a set of said glucose concentrations defined by class.
19. The apparatus of Claim 16, wherein said cluster comprises at least one of: a group of points representing said glucose concentrations represented on two or more axes; and a group of points relative to a threshold.
20. The apparatus of Claim 19, wherein said axes comprise any of linear, nonlinear, average, maximum, and area representations.
21. The apparatus of Claim 18, wherein said class comprises any of: a normal reading; 61
a pre-ciiabetic reading; a diabetic reading; a hypoglycemic reading; and a hyperglycemic reading.
22. The apparatus of Claim 16, wherein said means for selection of a cluster comprises a user interface module.
23. The apparatus of Claim 22, wherein said user interface module comprises any of; a touch screen; a stylus; a keyboard; and a button driven interface, whereby selection of at least one of said historical glucose concentrations is performed.
24, The apparatus of Claim 23, wherein said means for selecting values of variables comprises any of: a look-up table; and a historical table.
25, The apparatus of Claim 24, wherein said means for selecting values of variables further comprises any of: a central processing unit; and a programmable logic device.
26. The apparatus of Claim 16, wherein said means for presentation comprises an output module,
27. The apparatus of Claim 26, wherein said output module comprises a graphic display.
28. The apparatus of Claim 27, wherein said graphic display comprises any: a pie graph; a histogram; a time of day analysis; a glucose treatment grid; and a tabulation of said values of variables associated with points in said cluster.
29. An apparatus for anaiyte concentration estimation, comprising: a noninvasive analyzer; means for audible output of said anaiyte concentration integrated into said analyzer, and wherein said audible output comprises any of: an earcon output; and a voice synthesized output.
30. The apparatus of Claim 29, wherein said earcon outputs comprises a motive.
31. The apparatus of Claim 29, wherein said audible output comprises a series of motives. 63
32. The apparatus of Claim 29, wherein said audible output correlates to said glucose concentration in any of pitch, timbre, register, and dynamic.
33. The apparatus of Claim 29, wherein said apparatus comprises: a sample module in a first housing; a base module in a second housing; and means for communication between said sample module and said base module.
34. The apparatus of Claim 33, wherein said sample module comprises a neaMnfrared source emitting energy from at least 1200 to 1800 nm.
35. The apparatus of Claim 29, wherein said analyte comprises glucose.
36. The apparatus of Claim 29, wherein said earcon output comprises: a motive having a rhythmic sequence of pitches structured to convey information through a link learned by a listener.
37. The apparatus of Claim 36, wherein said motive comprises: a succession of pitches arranged to produce a tonal pattern.
38. The apparatus of Claim 29, further comprising; means for tactile output of said analyte concentration, wherein said analyte concentration comprises a glucose concentration.
39. The apparatus of Claim 29, wherein said audible output further comprises voice synthesis of said analyte concentration, wherein said analyte concentration comprises a glucose concentration. 64
40. The apparatus of Claim 1 , wherein said historical analyte concentrations comprise glucose concentration histories in terms of risk behavior.
41. The apparatus of Claim 1 , wherein said display module displays: a histogram of glucose concentrations of an individual,
42. The apparatus of Claim 1, wherein said display module displays: an updateable and replayable bar graph presentation of glucose concentrations of an individual.
43. The apparatus of Claim 1 , wherein said historical analyte concentrations comprise glucose concentrations resulting from a cluster analysis.
44. The apparatus of Claim 1 , wherein said near-infrared analyzer comprises: a base module; and a sample module, wherein said base module is physically separated from said sample module, and wherein said base module connects to said sample module via a communication bundle.
45. The apparatus of Claim 44, wherein said communication bundle comprises wireless communication. 65
46. The apparatus of Claim 44, wherein said display module comprises a portion of said base module.
47. The apparatus of Claim 44, wherein said display module comprises a portion of said sample module.
48. The apparatus of Claim 1 , wherein a subset of glucose concentrations represent said historical analyte concentrations, wherein said subset of glucose concentrations comprise a selected time of day dependent cluster of said historical analyze concentrations.
49. The apparatus of Claim 1 , wherein said display module displays a tachometer representation of said historical analyte concentrations.
50. The apparatus of Claim 1 , wherein a selected cluster of glucose concentrations of said historical analyte concentrations are represented on said display module, wherein said selected cluster comprises diabetic glucose concentrations.
PCT/US2005/000420 2004-01-06 2005-01-06 Method and apparatus for presentation of noninvasive glucose concentration information WO2005067633A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53482904P 2004-01-06 2004-01-06
US60/534,829 2004-01-06
US11/012,428 2004-12-14
US11/012,428 US7440786B2 (en) 2002-03-08 2004-12-14 Method and apparatus for presentation of noninvasive glucose concentration information

Publications (3)

Publication Number Publication Date
WO2005067633A2 WO2005067633A2 (en) 2005-07-28
WO2005067633A3 WO2005067633A3 (en) 2006-05-18
WO2005067633B1 true WO2005067633B1 (en) 2006-07-06

Family

ID=34752345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/000420 WO2005067633A2 (en) 2004-01-06 2005-01-06 Method and apparatus for presentation of noninvasive glucose concentration information

Country Status (2)

Country Link
US (2) US7440786B2 (en)
WO (1) WO2005067633A2 (en)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
EP1404234B1 (en) 2001-06-12 2011-02-09 Pelikan Technologies Inc. Apparatus for improving success rate of blood yield from a fingerstick
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US20080172026A1 (en) 2006-10-17 2008-07-17 Blomquist Michael L Insulin pump having a suspension bolus
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7491178B2 (en) * 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US6749582B2 (en) 2002-04-30 2004-06-15 The First Years Inc. Pumping breast milk
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US8475385B2 (en) * 2004-10-19 2013-07-02 The University Of Queensland Method and apparatus for physiological monitoring
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US8190223B2 (en) 2005-03-01 2012-05-29 Masimo Laboratories, Inc. Noninvasive multi-parameter patient monitor
US20090312620A1 (en) * 2005-04-27 2009-12-17 Hou-Mei Henry Chang Diabetes monitor
WO2007081853A2 (en) * 2006-01-05 2007-07-19 University Of Virginia Patent Foundation Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data
US8021310B2 (en) * 2006-04-21 2011-09-20 Nellcor Puritan Bennett Llc Work of breathing display for a ventilation system
US20080177149A1 (en) * 2006-06-16 2008-07-24 Stefan Weinert System and method for collecting patient information from which diabetes therapy may be determined
US20080154513A1 (en) * 2006-12-21 2008-06-26 University Of Virginia Patent Foundation Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
US8579814B2 (en) * 2007-01-05 2013-11-12 Idexx Laboratories, Inc. Method and system for representation of current and historical medical data
EP1952756A1 (en) 2007-01-31 2008-08-06 F.Hoffmann-La Roche Ag Data processing device for processing readings from a blood sugar measurement device
US20080228056A1 (en) 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
US20080234943A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
US20080235053A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Communication medium for diabetes management
WO2008118993A1 (en) 2007-03-27 2008-10-02 Masimo Laboratories, Inc. Multiple wavelength optical sensor
US8374665B2 (en) 2007-04-21 2013-02-12 Cercacor Laboratories, Inc. Tissue profile wellness monitor
US8221345B2 (en) 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
EP2299904B1 (en) 2008-06-06 2019-09-11 Intuity Medical, Inc. Medical measurement method
WO2010083485A2 (en) 2009-01-16 2010-07-22 Learning Curve Brands, Inc. Breast pump and method of use
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8608656B2 (en) * 2009-04-01 2013-12-17 Covidien Lp System and method for integrating clinical information to provide real-time alerts for improving patient outcomes
US8320985B2 (en) * 2009-04-02 2012-11-27 Empire Technology Development Llc Touch screen interfaces with pulse oximetry
US8786575B2 (en) * 2009-05-18 2014-07-22 Empire Technology Development LLP Touch-sensitive device and method
US20100331652A1 (en) * 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Modular diabetes management systems
US9218453B2 (en) * 2009-06-29 2015-12-22 Roche Diabetes Care, Inc. Blood glucose management and interface systems and methods
EP2455875A3 (en) * 2009-06-30 2013-01-16 Lifescan Scotland Limited System and method for diabetes management
KR101632308B1 (en) * 2009-09-23 2016-06-21 삼성전자주식회사 Method and apparatus for providing blood glucose management information
JP5394501B2 (en) 2009-10-02 2014-01-22 シャープ株式会社 Blood vessel condition monitoring method
US20110082711A1 (en) 2009-10-06 2011-04-07 Masimo Laboratories, Inc. Personal digital assistant or organizer for monitoring glucose levels
US9839381B1 (en) 2009-11-24 2017-12-12 Cercacor Laboratories, Inc. Physiological measurement system with automatic wavelength adjustment
DE112010004682T5 (en) 2009-12-04 2013-03-28 Masimo Corporation Calibration for multi-level physiological monitors
WO2011114578A1 (en) 2010-03-19 2011-09-22 シャープ株式会社 Measurement device, measurement method, measurement result processing device, measurement system, measurement result processing method, control program, and recording medium
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US20120226117A1 (en) 2010-12-01 2012-09-06 Lamego Marcelo M Handheld processing device including medical applications for minimally and non invasive glucose measurements
US9262586B2 (en) 2010-12-20 2016-02-16 Roche Diabetes Care, Inc. Representation of large, variable size data sets on small displays
EP3584799B1 (en) 2011-10-13 2022-11-09 Masimo Corporation Medical monitoring hub
US9159148B2 (en) * 2011-11-02 2015-10-13 Covidien Lp System, method, and software for displaying parameter values with historical ranges
WO2013090791A1 (en) 2011-12-15 2013-06-20 Becton, Dickinson And Company Near field telemetry link for passing a shared secret to establish a secure radio frequency communication link in a physiological condition monitoring system
DE102012100794B3 (en) * 2012-01-31 2013-02-28 Airbus Operations Gmbh Apparatus and method for detecting contaminants in a hydraulic system
US10149616B2 (en) 2012-02-09 2018-12-11 Masimo Corporation Wireless patient monitoring device
US11798685B2 (en) 2012-05-15 2023-10-24 James M. Minor Diagnostic methods and devices for controlling acute glycemia
US9585604B2 (en) 2012-07-16 2017-03-07 Zyomed Corp. Multiplexed pathlength resolved noninvasive analyzer apparatus with dynamic optical paths and method of use thereof
US9351672B2 (en) 2012-07-16 2016-05-31 Timothy Ruchti Multiplexed pathlength resolved noninvasive analyzer apparatus with stacked filters and method of use thereof
US9351671B2 (en) 2012-07-16 2016-05-31 Timothy Ruchti Multiplexed pathlength resolved noninvasive analyzer apparatus and method of use thereof
US9766126B2 (en) 2013-07-12 2017-09-19 Zyomed Corp. Dynamic radially controlled light input to a noninvasive analyzer apparatus and method of use thereof
US9504412B2 (en) * 2012-09-17 2016-11-29 Lifescan, Inc. Method and system to derive glycemic patterns from clustering of glucose data
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
CA2895538A1 (en) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
FI20135852A (en) * 2013-08-21 2015-03-06 Modz Oy Apparatus and systems for measuring and presenting the glucose level in the blood
WO2015148387A2 (en) * 2014-03-22 2015-10-01 Cannon, Alan, W. Diagnostic methods and devices for controlling acute glycemia
US10380323B2 (en) 2014-03-28 2019-08-13 Jesse Israel Kinbarovsky System and method for providing audiovisual feedback
US10453562B2 (en) * 2014-05-08 2019-10-22 ProductVisionaries, LLC Consumer-oriented biometrics data management and analysis system
US9265903B2 (en) 2014-05-27 2016-02-23 Covidien Lp Ventilation vitality ring
US9459201B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
US20160328990A1 (en) 2015-05-07 2016-11-10 Dexcom, Inc. System and method for educating users, including responding to patterns
WO2017035024A1 (en) * 2015-08-21 2017-03-02 Medtronic Minimed, Inc. Data analytics and insight delivery for the management and control of diabetes
US10664569B2 (en) 2015-08-21 2020-05-26 Medtronic Minimed, Inc. Data analytics and generation of recommendations for controlling glycemic outcomes associated with tracked events
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
EP3307792B1 (en) 2016-06-29 2018-10-24 Wacker Chemie AG Method for producing vinyl acetate-ethylene copolymers by means of emulsion polymerization
US10506926B2 (en) 2017-02-18 2019-12-17 Arc Devices Limited Multi-vital sign detector in an electronic medical records system
US10492684B2 (en) 2017-02-21 2019-12-03 Arc Devices Limited Multi-vital-sign smartphone system in an electronic medical records system
CN116759088A (en) * 2017-03-08 2023-09-15 雅培糖尿病护理公司 Systems and methods for health and nutrition monitoring and management using analytical data
WO2019014594A1 (en) * 2017-07-13 2019-01-17 Desborough Lane Multi-scale display of blood glucose information
US10602987B2 (en) 2017-08-10 2020-03-31 Arc Devices Limited Multi-vital-sign smartphone system in an electronic medical records system
US10485431B1 (en) 2018-05-21 2019-11-26 ARC Devices Ltd. Glucose multi-vital-sign system in an electronic medical records system
US20200043606A1 (en) * 2018-08-02 2020-02-06 Cnoga Medical Ltd. System and method for controlling blood glucose using personalized histograms
WO2021247300A1 (en) 2020-06-01 2021-12-09 Arc Devices Limited Apparatus and methods for measuring blood pressure and other vital signs via a finger
US11426102B2 (en) * 2020-06-30 2022-08-30 Dexcom, Inc. Diabetes prediction using glucose measurements and machine learning

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5411065Y2 (en) * 1975-08-11 1979-05-19
US4281645A (en) * 1977-06-28 1981-08-04 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs
JPS6043134B2 (en) * 1977-08-25 1985-09-26 信紘 佐藤 Device for measuring reflection characteristics of biological organs and tissues
US4272040A (en) * 1978-07-14 1981-06-09 General Dynamics, Pomona Division Aerodynamic control mechanism for thrust vector control
US4830014A (en) * 1983-05-11 1989-05-16 Nellcor Incorporated Sensor having cutaneous conformance
US4674338A (en) * 1984-12-31 1987-06-23 Lake Charles Instruments, Inc. Flow volume detection device
US4685464A (en) * 1985-07-05 1987-08-11 Nellcor Incorporated Durable sensor for detecting optical pulses
US4866644A (en) * 1986-08-29 1989-09-12 Shenk John S Optical instrument calibration system
US4798955A (en) * 1987-09-23 1989-01-17 Futrex, Inc. Measurement locator and light shield for use in interactance testing of body composition and method for use thereof
US5596987A (en) * 1988-11-02 1997-01-28 Noninvasive Technology, Inc. Optical coupler for in vivo examination of biological tissue
JP2766317B2 (en) * 1989-06-22 1998-06-18 コーリン電子株式会社 Pulse oximeter
WO1991003755A1 (en) * 1989-08-29 1991-03-21 Fibotech, Inc. High precision fiberoptic alignment spring receptacle and fiberoptic probe
US5007423A (en) * 1989-10-04 1991-04-16 Nippon Colin Company Ltd. Oximeter sensor temperature control
EP0613652B1 (en) * 1990-02-15 1997-04-16 Hewlett-Packard GmbH Apparatus and method for non-invasive measurement of oxygen saturation
EP0527703B1 (en) * 1991-08-12 1995-06-28 AVL Medical Instruments AG Device for measuring at least one gaseous concentration level in particular the oxygen concentration level in blood
US5239366A (en) * 1992-02-12 1993-08-24 Huges Aircraft Company Compact laser probe for profilometry
US5348003A (en) * 1992-09-03 1994-09-20 Sirraya, Inc. Method and apparatus for chemical analysis
US5398681A (en) * 1992-12-10 1995-03-21 Sunshine Medical Instruments, Inc. Pocket-type instrument for non-invasive measurement of blood glucose concentration
US5636634A (en) * 1993-03-16 1997-06-10 Ep Technologies, Inc. Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes
US5517301A (en) * 1993-07-27 1996-05-14 Hughes Aircraft Company Apparatus for characterizing an optic
JPH0799027A (en) * 1993-08-05 1995-04-11 Mitsubishi Electric Corp Electron beam focusing device
US5492118A (en) * 1993-12-16 1996-02-20 Board Of Trustees Of The University Of Illinois Determining material concentrations in tissues
US5632273A (en) * 1994-02-04 1997-05-27 Hamamatsu Photonics K.K. Method and means for measurement of biochemical components
DE4415896A1 (en) * 1994-05-05 1995-11-09 Boehringer Mannheim Gmbh Analysis system for monitoring the concentration of an analyte in the blood of a patient
DE4417639A1 (en) * 1994-05-19 1995-11-23 Boehringer Mannheim Gmbh Analysis of concns. of substances in a biological sample
US5912656A (en) * 1994-07-01 1999-06-15 Ohmeda Inc. Device for producing a display from monitored data
EP0722691A1 (en) * 1994-12-24 1996-07-24 Roche Diagnostics GmbH System for determining properties of tissue
DE19506484C2 (en) * 1995-02-24 1999-09-16 Stiftung Fuer Lasertechnologie Method and device for selective non-invasive laser myography (LMG)
WO1996033459A1 (en) * 1995-04-18 1996-10-24 International Business Machines Corporation High available error self-recovering shared cache for multiprocessor systems
US5730140A (en) * 1995-04-28 1998-03-24 Fitch; William Tecumseh S. Sonification system using synthesized realistic body sounds modified by other medically-important variables for physiological monitoring
JPH08299310A (en) * 1995-05-02 1996-11-19 Toa Medical Electronics Co Ltd Non-invasive blood analysis device and method therefor
US6095974A (en) * 1995-07-21 2000-08-01 Respironics, Inc. Disposable fiber optic probe
SG38866A1 (en) * 1995-07-31 1997-04-17 Instrumentation Metrics Inc Liquid correlation spectrometry
US6240306B1 (en) * 1995-08-09 2001-05-29 Rio Grande Medical Technologies, Inc. Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
US5636633A (en) * 1995-08-09 1997-06-10 Rio Grande Medical Technologies, Inc. Diffuse reflectance monitoring apparatus
US5655530A (en) * 1995-08-09 1997-08-12 Rio Grande Medical Technologies, Inc. Method for non-invasive blood analyte measurement with improved optical interface
JPH09122128A (en) * 1995-10-31 1997-05-13 Kdk Corp Measurement condition reproducing tool, measurement condition reproducing method and biological information utilizing the same
US5619195A (en) * 1995-12-29 1997-04-08 Charles D. Hayes Multi-axial position sensing apparatus
US5661843A (en) * 1996-01-30 1997-08-26 Rifocs Corporation Fiber optic probe
US6040578A (en) * 1996-02-02 2000-03-21 Instrumentation Metrics, Inc. Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy
US5747806A (en) * 1996-02-02 1998-05-05 Instrumentation Metrics, Inc Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy
AU2052997A (en) * 1996-02-23 1997-09-10 Diasense, Inc. Method and apparatus for non-invasive blood glucose sensing
US5725480A (en) * 1996-03-06 1998-03-10 Abbott Laboratories Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds
US6253097B1 (en) * 1996-03-06 2001-06-26 Datex-Ohmeda, Inc. Noninvasive medical monitoring instrument using surface emitting laser devices
US5877664A (en) * 1996-05-08 1999-03-02 Jackson, Jr.; John T. Magnetic proximity switch system
US5671317A (en) * 1996-07-16 1997-09-23 Health Research, Inc. Fiber optic positioner
US6027459A (en) * 1996-12-06 2000-02-22 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US6415167B1 (en) * 2000-05-02 2002-07-02 Instrumentation Metrics, Inc. Fiber optic probe placement guide
WO2002065090A2 (en) * 2001-01-26 2002-08-22 Sensys Medical Noninvasive measurement of glucose through the optical properties of tissue
US7039446B2 (en) * 2001-01-26 2006-05-02 Sensys Medical, Inc. Indirect measurement of tissue analytes through tissue properties
US6115673A (en) * 1997-08-14 2000-09-05 Instrumentation Metrics, Inc. Method and apparatus for generating basis sets for use in spectroscopic analysis
US5869075A (en) * 1997-08-15 1999-02-09 Kimberly-Clark Worldwide, Inc. Soft tissue achieved by applying a solid hydrophilic lotion
US5956150A (en) * 1998-02-02 1999-09-21 Motorola, Inc. Laser mount positioning device and method of using same
GB9807832D0 (en) * 1998-04-09 1998-06-10 Isis Innovation Imaging apparatus
WO1999058050A1 (en) * 1998-05-13 1999-11-18 Cygnus, Inc. Signal processing for measurement of physiological analytes
ATE246356T1 (en) * 1998-05-13 2003-08-15 Cygnus Therapeutic Systems DEVICE FOR PREDICTING PHYSIOLOGICAL MEASUREMENTS
US6662030B2 (en) * 1998-05-18 2003-12-09 Abbott Laboratories Non-invasive sensor having controllable temperature feature
US5891021A (en) * 1998-06-03 1999-04-06 Perdue Holdings, Inc. Partially rigid-partially flexible electro-optical sensor for fingertip transillumination
US6558320B1 (en) * 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6180416B1 (en) * 1998-09-30 2001-01-30 Cygnus, Inc. Method and device for predicting physiological values
US6157041A (en) * 1998-10-13 2000-12-05 Rio Grande Medical Technologies, Inc. Methods and apparatus for tailoring spectroscopic calibration models
US6441388B1 (en) * 1998-10-13 2002-08-27 Rio Grande Medical Technologies, Inc. Methods and apparatus for spectroscopic calibration model transfer
US6585370B2 (en) * 1998-11-02 2003-07-01 Gary M. Zelman Removable lens frame mounted to an eyewear platform
US6411838B1 (en) * 1998-12-23 2002-06-25 Medispectra, Inc. Systems and methods for optical examination of samples
US6067463A (en) * 1999-01-05 2000-05-23 Abbott Laboratories Method and apparatus for non-invasively measuring the amount of glucose in blood
US6405065B1 (en) * 1999-01-22 2002-06-11 Instrumentation Metrics, Inc. Non-invasive in vivo tissue classification using near-infrared measurements
US6280381B1 (en) * 1999-07-22 2001-08-28 Instrumentation Metrics, Inc. Intelligent system for noninvasive blood analyte prediction
US6959211B2 (en) * 1999-03-10 2005-10-25 Optiscan Biomedical Corp. Device for capturing thermal spectra from tissue
US6839583B1 (en) * 1999-06-03 2005-01-04 Hutchinson Technology Corporation Disposable tissue probe tip
CA2375635A1 (en) * 1999-07-14 2001-01-18 Providence Health System-Oregon Adaptive calibration pulsed oximetry method and device
US6442408B1 (en) * 1999-07-22 2002-08-27 Instrumentation Metrics, Inc. Method for quantification of stratum corneum hydration using diffuse reflectance spectroscopy
US6512937B2 (en) * 1999-07-22 2003-01-28 Sensys Medical, Inc. Multi-tier method of developing localized calibration models for non-invasive blood analyte prediction
US6411373B1 (en) * 1999-10-08 2002-06-25 Instrumentation Metrics, Inc. Fiber optic illumination and detection patterns, shapes, and locations for use in spectroscopic analysis
US20020087949A1 (en) * 2000-03-03 2002-07-04 Valery Golender System and method for software diagnostics using a combination of visual and dynamic tracing
FR2806609B1 (en) * 2000-03-24 2002-10-11 Medick S A METHOD AND DEVICE FOR NON-INVASIVE MEASUREMENT OF TISSUE AND IN PARTICULAR OF THE BILIRUBIN LEVEL OF THE SKIN
US6334360B1 (en) * 2000-05-09 2002-01-01 Po-Huei Chen Water level controller with conductance terminals
US6400974B1 (en) * 2000-06-29 2002-06-04 Sensors For Medicine And Science, Inc. Implanted sensor processing system and method for processing implanted sensor output
AU2002230429A1 (en) * 2000-11-13 2002-05-21 Argose, Inc. Reduction of spectral site to site variation
US6512982B2 (en) * 2000-12-20 2003-01-28 General Electric Company Methods and systems for evaluating defects in metals
US6574490B2 (en) * 2001-04-11 2003-06-03 Rio Grande Medical Technologies, Inc. System for non-invasive measurement of glucose in humans
EP1429832A4 (en) * 2001-09-28 2010-06-09 Rxtrocar Ltd Trocar-cannula complex, cannula and method for delivering fluids during minimally invasive surgery
US6756751B2 (en) * 2002-02-15 2004-06-29 Active Precision, Inc. Multiple degree of freedom substrate manipulator
US20050054908A1 (en) * 2003-03-07 2005-03-10 Blank Thomas B. Photostimulation method and apparatus in combination with glucose determination
US20050187439A1 (en) * 2003-03-07 2005-08-25 Blank Thomas B. Sampling interface system for in-vivo estimation of tissue analyte concentration
US6690958B1 (en) * 2002-05-07 2004-02-10 Nostix Llc Ultrasound-guided near infrared spectrophotometer
US20040077937A1 (en) * 2002-10-21 2004-04-22 Remon Medical Technologies Ltd Apparatus and method for coupling a medical device to a body surface
US20040163032A1 (en) * 2002-12-17 2004-08-19 Jin Guo Ambiguity resolution for predictive text entry
US6920345B2 (en) * 2003-01-24 2005-07-19 Masimo Corporation Optical sensor including disposable and reusable elements
US6922063B2 (en) * 2003-07-11 2005-07-26 Zircon Corporation Apparatus and method for capacitive level sensor
US7178063B1 (en) * 2003-07-22 2007-02-13 Hewlett-Packard Development Company, L.P. Method and apparatus for ordering test cases for regression testing
US8282549B2 (en) * 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
US7316009B2 (en) * 2003-08-06 2008-01-01 National Instruments Corporation Emulation of a programmable hardware element
US20080033275A1 (en) * 2004-04-28 2008-02-07 Blank Thomas B Method and Apparatus for Sample Probe Movement Control
US20080009835A1 (en) * 2005-02-17 2008-01-10 Kriesel Marshall S Fluid dispensing apparatus with flow rate control
US7409330B2 (en) * 2005-06-16 2008-08-05 Kabushiki Kaisha Toshiba Method and system for software debugging using a simulator

Also Published As

Publication number Publication date
US20050209515A1 (en) 2005-09-22
US20050159656A1 (en) 2005-07-21
WO2005067633A3 (en) 2006-05-18
WO2005067633A2 (en) 2005-07-28
US7440786B2 (en) 2008-10-21

Similar Documents

Publication Publication Date Title
WO2005067633B1 (en) Method and apparatus for presentation of noninvasive glucose concentration information
JP6938618B2 (en) Systems and methods for visualization of health data, as well as user assistance tools for continuous glucose monitoring
JP6553152B2 (en) Interface for Health Measurement and Monitoring System
US20200163628A1 (en) Noninvasive sensor system with visual infographic display
EP2643782B1 (en) Systems and methods to assess cognitive function
US7765111B2 (en) Method and apparatus for remote health monitoring and providing health related information
US7258666B2 (en) System and methods for monitoring a patient's heart condition
US20060095225A1 (en) Method and computer program for pattern analysis and reporting of chronic disease state management data
JP2014502858A (en) Analyte test method and system with high and low analyte trend notification
US10939857B2 (en) Three-dimensionally printed blood glucose sensing device and fabrication method
CN108135503A (en) The medical monitoring analysis and playback of label including the light in response to being decayed by bodily tissue
JP2021114317A (en) Control of computer by distortion of geometric shape of face
WO2004034898A3 (en) Method for the presentation of information concerning variations of the perfusion
US20100152554A1 (en) Monitoring device
US20080195980A1 (en) System, apparatus and method for emotional experience time sampling via a mobile graphical user interface
US20070299321A1 (en) Method and apparatus for remote health monitoring and providing health related information
KR20090079841A (en) Analyte testing method and system
CN102483775A (en) Analyte testing method and system
JP2008167937A (en) Fitness exercise condition display device
Pavel et al. From self-monitoring to self-understanding: Going beyond physiological sensing for supporting wellbeing
US20120310059A1 (en) Clinical Acceptance Tool
Hirschmann et al. Evaluation of an interactive visualization tool for the interpretation of pediatric laboratory test results
US20220143460A1 (en) Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations
Fan et al. Health pal: a PDA phone that will take care of your health
JP3101724U (en) Electronic diary

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase